Founder of Kew, Inc. and The Coalition for 21st Century Medicine, M. Kathleen Behrens Wilsey presently occupies the position of Chairman for Sarepta Therapeutics, Inc. and Chairman for MiMedx Group, Inc. Dr. Wilsey is also on the board of IGM Biosciences, Inc. Dr. Wilsey previously was Chairman & President for National Venture Capital Association, President & Chief Executive Officer of Kew, Inc., Managing Director at RS Investment Management Co. LLC, Managing Director & General Partner at Robertson Stephens & Co. and Director-Science, Technology & Economic Policy at The National Research Council. M. Kathleen Behrens Wilsey received an undergraduate degree and a doctorate from the University of California, Davis.